Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?
暂无分享,去创建一个
M. Irwin | P. Ganz | J. Bower | S. Cole | L. Kwan | Michael R Irwin | Patricia A Ganz | Lorna Kwan | Julienne E Bower | Elizabeth C Breen | Steve W Cole | E. Breen
[1] B. Mausbach,et al. Sleep and Biomarkers of Atherosclerosis in Elderly Alzheimer Caregivers and Controls , 2009, Gerontology.
[2] P. Jacobsen,et al. The Fatigue Symptom Inventory: a systematic review of its psychometric properties , 2011, Supportive Care in Cancer.
[3] J. Dimsdale,et al. The association between interleukin-6, sleep, and demographic characteristics , 2005, Brain, Behavior, and Immunity.
[4] S. Ancoli-Israel,et al. The Effects of Standard Anthracycline-Based Chemotherapy on Soluble ICAM-1 and Vascular Endothelial Growth Factor Levels in Breast Cancer , 2004, Clinical Cancer Research.
[5] P. Ganz,et al. Fatigue in long‐term breast carcinoma survivors , 2006, Cancer.
[6] G. Lyman,et al. Measurement of Fatigue in Cancer Patients: Development and Validation of the Fatigue Symptom Inventory , 1998, Quality of Life Research.
[7] S. Fosså,et al. Predictors and course of chronic fatigue in long-term breast cancer survivors , 2010, Journal of cancer survivorship : research and practice.
[8] G. Lyman,et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. , 1999, Journal of pain and symptom management.
[9] M. Irwin,et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors , 2006, Brain, Behavior, and Immunity.
[10] P. Ganz,et al. Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer , 2009, Clinical Cancer Research.
[11] J. Bower. Behavioral symptoms in patients with breast cancer and survivors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Suarez. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: Evidence for gender disparity , 2008, Brain, Behavior, and Immunity.
[13] L. Natarajan,et al. Inflammation and sleep in healthy individuals. , 2007, Sleep.
[14] D. Butterfield,et al. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. , 2006, Neurobiology of disease.
[15] R. Dantzer,et al. A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms , 2004, Neuroimmunomodulation.
[16] C. Morin,et al. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. , 2001, Sleep.
[17] D. Cella,et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] C. Cleeland,et al. Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation , 2008, Cancer.
[19] J. Born,et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. , 1998, The Journal of clinical endocrinology and metabolism.
[20] C. Nemeroff,et al. Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions , 2002, Neuropsychopharmacology.
[21] T. Pollmächer,et al. Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.
[22] Tristen K. Inagaki,et al. Inflammation and social experience: An inflammatory challenge induces feelings of social disconnection in addition to depressed mood , 2010, Brain, Behavior, and Immunity.
[23] P. Fayers,et al. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients , 2007, Breast Cancer Research and Treatment.
[24] C. Morin,et al. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] F. Penedo,et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Ockene,et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI) , 2004 .
[27] Daniel J Buysse,et al. Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI) , 1991, Sleep.
[28] Jennifer L Martin,et al. To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers , 2009, Brain, Behavior, and Immunity.
[29] Ingrid J Orre,et al. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue , 2009, Brain, Behavior, and Immunity.
[30] P. Jacobsen,et al. Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. , 2008, Journal of pain and symptom management.
[31] D. Papanicolaou,et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. , 1997, The Journal of clinical endocrinology and metabolism.
[32] Patricia A. Ganz,et al. Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors , 2002, Psychosomatic medicine.
[33] L. Hawkley,et al. Psychosocial and Behavioral Predictors of Inflammation in Middle-Aged and Older Adults: The Chicago Health, Aging, and Social Relations Study , 2006, Psychosomatic medicine.
[34] P. Flynn,et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] D. Butterfield,et al. Adriamycin-induced, TNF-α-mediated central nervous system toxicity , 2006, Neurobiology of Disease.
[36] M. Caligiuri,et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Baldwin M. Way,et al. Neural sensitivity to social rejection is associated with inflammatory responses to social stress , 2010, Proceedings of the National Academy of Sciences.
[38] Julie L Otte,et al. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. , 2010, Journal of pain and symptom management.
[39] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[40] V. Meyer-Rochow,et al. C-reactive protein Levels and Sleep Disturbances: Observations Based on The Northern Finland 1966 Birth Cohort Study , 2007, Psychosomatic medicine.
[41] P. Jacobsen,et al. Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. , 2004, Journal of pain and symptom management.
[42] S. Ancoli-Israel,et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer , 2005, Biological Psychology.
[43] P. Buckley,et al. Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer , 2009 .
[44] M. Irwin,et al. Effects of sleep and sleep loss on immunity and cytokines , 2002, Brain, Behavior, and Immunity.
[45] J. Suls,et al. Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.
[46] P. Ganz,et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Heather L. Urry,et al. Social relationships, sleep quality, and interleukin-6 in aging women. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] G. Tilz,et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis , 1995, European journal of haematology.
[49] C. Cleeland,et al. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy , 2010, Brain, Behavior, and Immunity.
[50] H. Jim,et al. Fatigue after treatment for early stage breast cancer , 2007, Cancer.
[51] P. Stone,et al. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome , 2009, European journal of cancer.
[52] J. Manson,et al. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. , 2005, Diabetes care.
[53] E. Bruera,et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. , 2004, Cytokine.
[54] G. Lyman,et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] M. Andrykowski,et al. Psychometric evaluation of the Pittsburgh Sleep Quality Index. , 1998, Journal of psychosomatic research.
[56] M. Massie. Prevalence of depression in patients with cancer. , 2004, Journal of the National Cancer Institute. Monographs.
[57] T. Patterson,et al. Poor Sleep Is Associated with Higher Plasma Proinflammatory Cytokine Interleukin‐6 and Procoagulant Marker Fibrin D‐Dimer in Older Caregivers of People with Alzheimer's Disease , 2006, Journal of the American Geriatrics Society.
[58] S. Ancoli-Israel,et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] P. Jacobsen,et al. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] C. Rock,et al. The relative importance of specific risk factors for insomnia in women treated for early‐stage breast cancer , 2008, Psycho-oncology.
[61] S. Ancoli-Israel,et al. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer , 2008, Brain, Behavior, and Immunity.